A study in Genomic Psychiatry, led by Troy T. Rohn of Boise State University and Cognigenics, found that people with Alzheimer's whose anxiety was frequent or constant scored clearly lower on cognitive testing than people with no anxiety. Participants who showed anxiety only occasionally, about once a week, did not differ from those with none. The pattern held up in data from the Alzheimer's Disease Neuroimaging Initiative, or ADNI, a long-running cohort that combines cognitive testing, brain imaging and genetic information.
Cognition was measured with the Mini-Mental State Examination, and anxiety came from structured interviews with caregivers asking how often the person seemed nervous, worried or frightened over the past month. That reliance on caregiver observation means the anxiety measured was the kind that family members could see day to day. Across the full range of behavioral symptoms, higher neuropsychiatric scores also went with lower cognition, and the link remained after adjusting for sex, education, diagnosis group and APOE ε4 status.
Amyloid, the protein that forms plaques in the brain, was also examined. Greater neuropsychiatric burden was associated with more cortical amyloid, but the authors concluded that amyloid did not explain the link between anxiety and cognitive decline. That led them to look at the serotonin 2A receptor, which helps regulate mood, anxiety and circuits involved in memory. In earlier rodent studies cited by the authors, suppressing this receptor reduced anxiety-related behavior and improved memory. The human genetic findings were suggestive but exploratory, with small subgroups and only weak associations.
The authors are clear that these are associations and do not show that anxiety causes cognitive decline or the reverse. No patients received Cog-201, the approach being developed in connection with Cognigenics, which most of the authors are affiliated with. The researchers propose a clinical trial to test that approach in patients with clinically significant anxiety, treating cognition and anxiety together rather than separately.